|
Mr. Hennessey served as CEO of Oscient Pharmaceuticals from 1993-2000. Prior to joining the Company in March 1993, Mr. Hennessey served as President of Hennessey & Associates, Ltd., a private consulting firm in the biotechnology and pharmaceutical industries. From 1980 to 1990, he served as a Corporate Vice President of Sterling Drug, Inc., a pharmaceutical company, in charge of strategic planning, acquisitions and licensing. Prior to Sterling Drug, Inc., Mr. Hennessey was Director, International Strategic Planning and Business Development at Abbott Laboratories, Inc., Managing Director, Biologicals of SmithKline Beecham Corporation and Director, International Business Development at Merck & Co., Inc., all of which are pharmaceutical companies. Mr. Hennessey currently serves on the Board of Directors for Penwest Pharmaceuticals Co. and holds a B.A. and M.A. from the University of Connecticut.
| 